Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Heart Failure with Volume Overload
NCT01439009Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in heart failure (HF), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Sep 2011; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01439009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439009.